1
|
Iori S, D'Onofrio C, Laham-Karam N, Mushimiyimana I, Lucatello L, Montanucci L, Lopparelli RM, Bonsembiante F, Capolongo F, Pauletto M, Dacasto M, Giantin M. Generation and characterization of cytochrome P450 3A74 CRISPR/Cas9 knockout bovine foetal hepatocyte cell line (BFH12). Biochem Pharmacol 2024; 224:116231. [PMID: 38648904 DOI: 10.1016/j.bcp.2024.116231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2023] [Revised: 04/04/2024] [Accepted: 04/19/2024] [Indexed: 04/25/2024]
Abstract
In human, the cytochrome P450 3A (CYP3A) subfamily of drug-metabolizing enzymes (DMEs) is responsible for a significant number of phase I reactions, with the CYP3A4 isoform superintending the hepatic and intestinal metabolism of diverse endobiotic and xenobiotic compounds. The CYP3A4-dependent bioactivation of chemicals may result in hepatotoxicity and trigger carcinogenesis. In cattle, four CYP3A genes (CYP3A74, CYP3A76, CYP3A28 and CYP3A24) have been identified. Despite cattle being daily exposed to xenobiotics (e.g., mycotoxins, food additives, drugs and pesticides), the existing knowledge about the contribution of CYP3A in bovine hepatic metabolism is still incomplete. Nowadays, CRISPR/Cas9 mediated knockout (KO) is a valuable method to generate in vivo and in vitro models for studying the metabolism of xenobiotics. In the present study, we successfully performed CRISPR/Cas9-mediated KO of bovine CYP3A74, human CYP3A4-like, in a bovine foetal hepatocyte cell line (BFH12). After clonal expansion and selection, CYP3A74 ablation was confirmed at the DNA, mRNA, and protein level. The subsequent characterization of the CYP3A74 KO clone highlighted significant transcriptomic changes (RNA-sequencing) associated with the regulation of cell cycle and proliferation, immune and inflammatory response, as well as metabolic processes. Overall, this study successfully developed a new CYP3A74 KO in vitro model by using CRISPR/Cas9 technology, which represents a novel resource for xenobiotic metabolism studies in cattle. Furthermore, the transcriptomic analysis suggests a key role of CYP3A74 in bovine hepatocyte cell cycle regulation and metabolic homeostasis.
Collapse
Affiliation(s)
- Silvia Iori
- Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy
| | - Caterina D'Onofrio
- Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy
| | - Nihay Laham-Karam
- University of Eastern Finland, A.I. Virtanen Institute for Molecular Sciences, Neulaniementie 2, 70211 Kuopio, Finland
| | - Isidore Mushimiyimana
- University of Eastern Finland, A.I. Virtanen Institute for Molecular Sciences, Neulaniementie 2, 70211 Kuopio, Finland
| | - Lorena Lucatello
- Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy
| | - Ludovica Montanucci
- Department of Neurology, University of Texas Health Science Center, 6431 Fannin Street, Houston, TX, OH 44106, USA
| | - Rosa Maria Lopparelli
- Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy
| | - Federico Bonsembiante
- Department of Animal Medicine, Production and Health, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy
| | - Francesca Capolongo
- Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy
| | - Marianna Pauletto
- Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy
| | - Mauro Dacasto
- Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy
| | - Mery Giantin
- Department of Comparative Biomedicine and Food Science, University of Padua, Viale dell'Università 16, Legnaro, 35020 Padua, Italy.
| |
Collapse
|
2
|
Vybornykh DE, Ivanov SV, Gemdzhian EG, Esina LV, Gaponova TV. [Therapy of mental disorders in patients with hematological malignancies]. Zh Nevrol Psikhiatr Im S S Korsakova 2024; 124:127-136. [PMID: 38676687 DOI: 10.17116/jnevro2024124041127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2024]
Abstract
OBJECTIVE To assess the possibilities of therapy with minimal effective doses (MED) of psychotropic drugs for mental disorders (MD) that manifest during the treatment of hematological malignancies (HM). MATERIAL AND METHODS A prospective study was conducted at the National Medical Research Center for Hematology of the Russian Ministry of Health (Moscow), which included 204 (39.4%) men and 314 (60.6%) women (518 patients in total), aged 17 to 83 years (median 45 years), with various HM, in which the manifestation of MD occurred during the treatment of the underlying disease. To minimize the side-effects of psychotropic drugs and given the relatively mild level of MD, psychopharmacotherapy of patients was carried out mainly at MED. The severity of MD, manifested in patients, was assessed by the illness severity scale of the Clinical Global Impression (CGI) scale, and the effectiveness of the treatment was assessed by the improvement scale (CGI-I). RESULTS Mainly mild (188, 36%) and moderately pronounced (270, 52%) MD were noted in patients with HM during the treatment of the underlying disease. Severe psychopathological disorders (60, 12%) were observed much less often. Because of psychopharmacotherapy with MED, patients experienced a very significant (97, 19%) and significant improvement (354, 68%) of their mental state, less often the improvement was regarded as minimal (67, 13%). Therefore, almost all patients showed a stable relief of MD; in 87% (95% CI 84-90) of patients, this improvement was significant. CONCLUSION The tactics of treatment MD that manifest in patients with HM with MED of psychotropic drugs turned out to be therapeutically effective according to the results of the assessment on CGI scales.
Collapse
Affiliation(s)
- D E Vybornykh
- National Medical Research Center for Hematology, Moscow, Russia
| | - S V Ivanov
- Mental Health Research Center, Moscow, Russia
- Sechenov First Moscow State Medical University, Moscow, Russia
| | - E G Gemdzhian
- National Medical Research Center for Hematology, Moscow, Russia
| | - L V Esina
- National Medical Research Center for Hematology, Moscow, Russia
- Sechenov First Moscow State Medical University, Moscow, Russia
| | - T V Gaponova
- National Medical Research Center for Hematology, Moscow, Russia
| |
Collapse
|
3
|
Lyubitelev A, Studitsky V. Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms. Int J Mol Sci 2023; 24:10663. [PMID: 37445850 PMCID: PMC10341686 DOI: 10.3390/ijms241310663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Revised: 06/08/2023] [Accepted: 06/09/2023] [Indexed: 07/15/2023] Open
Abstract
Malignant tumors remain one of the main sources of morbidity and mortality around the world. A chemotherapeutic approach to cancer treatment poses a multitude of challenges, primarily due to the low selectivity and genotoxicity of the majority of chemotherapeutic drugs currently used in the clinical practice, often leading to treatment-induced tumors formation. Highly selective antitumor drugs can largely resolve this issue, but their high selectivity leads to significant drawbacks due to the intrinsic tumor heterogeneity. In contrast, plant polyphenols can simultaneously affect many processes that are involved in the acquiring and maintaining of hallmark properties of malignant cells, and their toxic dose is typically much higher than the therapeutic one. In the present work we describe the mechanisms of the action of polyphenols on cancer cells, including their effects on genetic and epigenetic instability, tumor-promoting inflammation, and altered microbiota.
Collapse
Affiliation(s)
| | - Vasily Studitsky
- Biology Faculty, Lomonosov Moscow State University, 119234 Moscow, Russia;
- Fox Chase Cancer Center, Philadelphia, PA 19111, USA
| |
Collapse
|
4
|
Zeng Z, Zheng W, Hou P. The role of drug-metabolizing enzymes in synthetic lethality of cancer. Pharmacol Ther 2022; 240:108219. [PMID: 35636517 DOI: 10.1016/j.pharmthera.2022.108219] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 05/23/2022] [Accepted: 05/24/2022] [Indexed: 12/14/2022]
Abstract
Drug-metabolizing enzymes (DMEs) have shown increasing importance in anticancer therapy. It is not only due to their effect on activation or deactivation of anticancer drugs, but also because of their extensive connections with pathological and biochemistry changes during tumorigenesis. Meanwhile, it has become more accessible to discovery anticancer drugs that selectively targeted cancer cells with the development of synthetic lethal screen technology. Synthetic lethal strategy makes use of unique genetic markers that different cancer cells from normal tissues to discovery anticancer agents. Dysregulation of DMEs has been found in various cancers, making them promising candidates for synthetic lethal strategy. In this review, we will systematically discuss about the role of DMEs in tumor progression, the application of synthetic lethality strategy in drug discovery, and a link between DMEs and synthetic lethal of cancer.
Collapse
Affiliation(s)
- Zekun Zeng
- Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China
| | - Wenfang Zheng
- Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China
| | - Peng Hou
- Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR China.
| |
Collapse
|
5
|
Jia X, Wen X, Russo DP, Aleksunes LM, Zhu H. Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay. JOURNAL OF HAZARDOUS MATERIALS 2022; 436:129193. [PMID: 35739723 PMCID: PMC9262097 DOI: 10.1016/j.jhazmat.2022.129193] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2022] [Revised: 05/13/2022] [Accepted: 05/17/2022] [Indexed: 05/20/2023]
Abstract
Traditional experimental approaches to evaluate hepatotoxicity are expensive and time-consuming. As an advanced framework of risk assessment, adverse outcome pathways (AOPs) describe the sequence of molecular and cellular events underlying chemical toxicities. We aimed to develop an AOP that can be used to predict hepatotoxicity by leveraging computational modeling and in vitro assays. We curated 869 compounds with known hepatotoxicity classifications as a modeling set and extracted assay data from PubChem. The antioxidant response element (ARE) assay, which quantifies transcriptional responses to oxidative stress, showed a high correlation to hepatotoxicity (PPV=0.82). Next, we developed quantitative structure-activity relationship (QSAR) models to predict ARE activation for compounds lacking testing results. Potential toxicity alerts were identified and used to construct a mechanistic hepatotoxicity model. For experimental validation, 16 compounds in the modeling set and 12 new compounds were selected and tested using an in-house ARE-luciferase assay in HepG2-C8 cells. The mechanistic model showed good hepatotoxicity predictivity (accuracy = 0.82) for these compounds. Potential false positive hepatotoxicity predictions by only using ARE results can be corrected by incorporating structural alerts and vice versa. This mechanistic model illustrates a potential toxicity pathway for hepatotoxicity, and this strategy can be expanded to develop predictive models for other complex toxicities.
Collapse
Affiliation(s)
- Xuelian Jia
- The Rutgers Center for Computational and Integrative Biology, Camden, NJ 08102, USA
| | - Xia Wen
- Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA
| | - Daniel P Russo
- The Rutgers Center for Computational and Integrative Biology, Camden, NJ 08102, USA
| | - Lauren M Aleksunes
- Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA
| | - Hao Zhu
- The Rutgers Center for Computational and Integrative Biology, Camden, NJ 08102, USA; Department of Chemistry, Rutgers University, Camden, NJ 08102, USA.
| |
Collapse
|
6
|
Lagunas‐Rangel FA, Linnea‐Niemi JV, Kudłak B, Williams MJ, Jönsson J, Schiöth HB. Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer. GEOHEALTH 2022; 6:e2021GH000552. [PMID: 35493962 PMCID: PMC9036628 DOI: 10.1029/2021gh000552] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Revised: 03/01/2022] [Accepted: 04/04/2022] [Indexed: 05/08/2023]
Abstract
There is a growing awareness that the large number of environmental pollutants we are exposed to on a daily basis are causing major health problems. Compared to traditional studies that focus on individual pollutants, there are relatively few studies on how pollutants mixtures interact. Several studies have reported a relationship between environmental pollutants and the development of cancer, even when pollutant levels are below toxicity reference values. The possibility of synergistic interactions between different pollutants could explain how even low concentrations can cause major health problems. These intricate that molecular interactions can occur through a wide variety of mechanisms, and our understanding of the physiological effects of mixtures is still limited. The purpose of this paper is to discuss recent reports that address possible synergistic interactions between different types of environmental pollutants that could promote cancer development. Our literature studies suggest that key biological pathways are frequently implicated in such processes. These include increased production of reactive oxygen species, activation by cytochrome P450, and aryl hydrocarbon receptor signaling, among others. We discuss the need to understand individual pathological vulnerability not only in relation to basic genetics and gene expression, but also in terms of measurable exposure to contaminants. We also mention the need for significant improvements in future studies using a multitude of disciplines, such as the development of high-throughput study models, better tools for quantifying pollutants in cancer patients, innovative pharmacological and toxicological studies, and high-efficiency computer analysis, which allow us to analyze the molecular mechanisms of mixtures.
Collapse
Affiliation(s)
| | - Jenni Viivi Linnea‐Niemi
- Department of Surgical Sciences, Functional Pharmacology and NeuroscienceUppsala UniversityUppsalaSweden
| | - Błażej Kudłak
- Faculty of ChemistryDepartment of Analytical ChemistryGdańsk University of TechnologyGdańskPoland
| | - Michael J. Williams
- Department of Surgical Sciences, Functional Pharmacology and NeuroscienceUppsala UniversityUppsalaSweden
| | - Jörgen Jönsson
- Department of Surgical Sciences, Functional Pharmacology and NeuroscienceUppsala UniversityUppsalaSweden
| | - Helgi B. Schiöth
- Department of Surgical Sciences, Functional Pharmacology and NeuroscienceUppsala UniversityUppsalaSweden
- Institute of Translational Medicine and BiotechnologyI. M. Sechenov First Moscow State Medical UniversityMoscowRussia
| |
Collapse
|
7
|
Lagunas-Rangel FA, Liu W, Schiöth HB. Can Exposure to Environmental Pollutants Be Associated with Less Effective Chemotherapy in Cancer Patients? INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19042064. [PMID: 35206262 PMCID: PMC8871977 DOI: 10.3390/ijerph19042064] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Revised: 02/07/2022] [Accepted: 02/09/2022] [Indexed: 02/05/2023]
Abstract
Since environmental pollutants are ubiquitous and many of them are resistant to degradation, we are exposed to many of them on a daily basis. Notably, these pollutants can have harmful effects on our health and be linked to the development of disease. Epidemiological evidence together with a better understanding of the mechanisms that link toxic substances with the development of diseases, suggest that exposure to some environmental pollutants can lead to an increased risk of developing cancer. Furthermore, several studies have raised the role of low-dose exposure to environmental pollutants in cancer progression. However, little is known about how these compounds influence the treatments given to cancer patients. In this work, we present a series of evidences suggesting that environmental pollutants such as bisphenol A (BPA), benzo[a]pyrene (BaP), persistent organic pollutants (POPs), aluminum chloride (AlCl3), and airborne particulate matter may reduce the efficacy of some common chemotherapeutic drugs used in different types of cancer. We discuss the potential underlying molecular mechanisms that lead to the generation of this chemoresistance, such as apoptosis evasion, DNA damage repair, activation of pro-cancer signaling pathways, drug efflux and action of antioxidant enzymes, among others.
Collapse
Affiliation(s)
- Francisco Alejandro Lagunas-Rangel
- Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, BMC Box 593, Husargatan 3, 75124 Uppsala, Sweden;
- Correspondence: (F.A.L.-R.); (H.B.S.)
| | - Wen Liu
- Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, BMC Box 593, Husargatan 3, 75124 Uppsala, Sweden;
| | - Helgi B. Schiöth
- Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, BMC Box 593, Husargatan 3, 75124 Uppsala, Sweden;
- Institute of Translational Medicine and Biotechnology, I. M. Sechenov First Moscow State Medical University, 8-2 Trubetskaya Str. Moscow, 119991 Moscow, Russia
- Correspondence: (F.A.L.-R.); (H.B.S.)
| |
Collapse
|
8
|
Mombeini MA, Kalantar H, Sadeghi E, Goudarzi M, Khalili H, Kalantar M. Protective effects of berberine as a natural antioxidant and anti-inflammatory agent against nephrotoxicity induced by cyclophosphamide in mice. NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY 2022; 395:187-194. [PMID: 34994821 DOI: 10.1007/s00210-021-02182-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 11/10/2021] [Indexed: 10/19/2022]
Abstract
PURPOSE Cyclophosphamide is an alkylating agent with nephrotoxicity that constrains its clinical application. Berberine is an isoquinoline derivative alkaloid with biological functions like antioxidant and anti-inflammatory. The current research intended to examine the nephroprotective impacts of berberine against cyclophosphamide-stimulated nephrotoxicity. METHODS Forty animal subjects were randomly separated into five categories of control (Group I), cyclophosphamide (200 mg/kg, i.p., on 7th day) (Group II), and groups III and IV that received berberine 50 and 100 mg/kg orally for seven days and a single injection of cyclophosphamide on 7th day. Group V as berberine (100 mg/kg, alone). On day 8, blood samples were drawn from the retro-orbital sinus to determine serum levels of blood urea nitrogen (BUN), creatinine (Cr), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) as biomarkers for kidney injury. Nitric oxide (NO), malondialdehyde (MDA) and glutathione (GSH) levels, catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx) activities as oxidative stress factors, tumor necrosis factor-α (TNF-α) and interleukin 1 beta (IL-1β) levels as inflammatory mediators were assessed in kidney tissue. RESULTS The results of this study demonstrated that berberine was able to protect remarkably the kidney from CP-induced injury through decreasing the level of BUN, Cr, NGAL, KIM-1, NO, MDA TNF-α, IL-1β and increasing the level of GSH, CAT, SOD, and GPx activities. CONCLUSION Berberine may be employed as a natural agent to prevent cyclophosphamide-induced nephrotoxicity through anti-oxidant and anti-inflammatory effects.
Collapse
Affiliation(s)
- Mohammad Amin Mombeini
- Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Hadi Kalantar
- Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Elahe Sadeghi
- Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Mehdi Goudarzi
- Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Hamidreza Khalili
- Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | | |
Collapse
|
9
|
Esteves F, Rueff J, Kranendonk M. The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family. J Xenobiot 2021; 11:94-114. [PMID: 34206277 PMCID: PMC8293344 DOI: 10.3390/jox11030007] [Citation(s) in RCA: 167] [Impact Index Per Article: 55.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Revised: 06/14/2021] [Accepted: 06/16/2021] [Indexed: 12/18/2022] Open
Abstract
Human Cytochrome P450 (CYP) enzymes constitute a superfamily of membrane-bound hemoproteins that are responsible for the metabolism of a wide variety of clinically, physiologically, and toxicologically important compounds. These heme-thiolate monooxygenases play a pivotal role in the detoxification of xenobiotics, participating in the metabolism of many structurally diverge compounds. This short-review is intended to provide a summary on the major roles of CYPs in Phase I xenobiotic metabolism. The manuscript is focused on eight main topics that include the most relevant aspects of past and current CYP research. Initially, (I) a general overview of the main aspects of absorption, distribution, metabolism, and excretion (ADME) of xenobiotics are presented. This is followed by (II) a background overview on major achievements in the past of the CYP research field. (III) Classification and nomenclature of CYPs is briefly reviewed, followed by (IV) a summary description on CYP's location and function in mammals. Subsequently, (V) the physiological relevance of CYP as the cornerstone of Phase I xenobiotic metabolism is highlighted, followed by (VI) reviewing both genetic determinants and (VI) nongenetic factors in CYP function and activity. The last topic of the review (VIII) is focused on the current challenges of the CYP research field.
Collapse
Affiliation(s)
- Francisco Esteves
- Center for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Huma Toxicology, NOVA Medical School/Faculty of Medical Sciences, Universidade NOVA de Lisboa, 1169-056 Lisboa, Portugal; (J.R.); (M.K.)
| | | | | |
Collapse
|
10
|
Sun D, Lu J, Zhang Y, Liu J, Liu Z, Yao B, Guo Y, Wang X. Characterization of a Novel CYP1A2 Knockout Rat Model Constructed by CRISPR/Cas9. Drug Metab Dispos 2021; 49:638-647. [PMID: 34074728 DOI: 10.1124/dmd.121.000403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Accepted: 05/04/2021] [Indexed: 11/22/2022] Open
Abstract
CYP1A2, as one of the most important cytochrome P450 isoforms, is involved in the biotransformation of many important endogenous and exogenous substances. CYP1A2 also plays an important role in the development of many diseases because it is involved in the biotransformation of precancerous substances and poisons. Although the generation of Cyp1a2 knockout (KO) mouse model has been reported, there are still no relevant rat models for the study of CYP1A2-mediated pharmacokinetics and diseases. In this report, CYP1A2 KO rat model was established successfully by CRISPR/Cas9 without any detectable off-target effect. Compared with wild-type rats, this model showed a loss of CYP1A2 protein expression in the liver. The results of pharmacokinetics in vivo and incubation in vitro of specific substrates of CYP1A2 confirmed the lack of function of CYP1A2 in KO rats. In further studies of potential compensatory effects, we found that CYP1A1 was significantly upregulated, and CYP2E1, CYP3A2, and liver X receptor β were downregulated in KO rats. In addition, CYP1A2 KO rats exhibited a significant increase in serum cholesterol and free testosterone accompanied by mild liver damage and lipid deposition, suggesting that CYP1A2 deficiency affects lipid metabolism and liver function to a certain extent. In summary, we successfully constructed the CYP1A2 KO rat model, which provides a useful tool for studying the metabolic function and physiologic function of CYP1A2. SIGNIFICANCE STATEMENT: Human CYP1A2 not only metabolizes clinical drugs and pollutants but also mediates the biotransformation of endogenous substances and plays an important role in the development of many diseases. However, there are no relevant CYP1A2 rat models for the research of pharmacokinetics and diseases. This study successfully established CYP1A2 knockout rat model by using CRISPR/Cas9. This rat model provides a powerful tool to study the function of CYP1A2 in drug metabolism and diseases.
Collapse
Affiliation(s)
- Dongyi Sun
- Changning Maternity and Infant Health Hospital (D.S., J.Lu, Y.Z., J.Liu, B.Y., Y.G., X.W.), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences (D.S, J.Lu, Y.Z., J.Liu, X.W.), East China Normal University, Shanghai, People's Republic of China and Department of Cardiology, Central Hospital of Shanghai Putuo District (Z.L.), Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Jian Lu
- Changning Maternity and Infant Health Hospital (D.S., J.Lu, Y.Z., J.Liu, B.Y., Y.G., X.W.), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences (D.S, J.Lu, Y.Z., J.Liu, X.W.), East China Normal University, Shanghai, People's Republic of China and Department of Cardiology, Central Hospital of Shanghai Putuo District (Z.L.), Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Yuanjin Zhang
- Changning Maternity and Infant Health Hospital (D.S., J.Lu, Y.Z., J.Liu, B.Y., Y.G., X.W.), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences (D.S, J.Lu, Y.Z., J.Liu, X.W.), East China Normal University, Shanghai, People's Republic of China and Department of Cardiology, Central Hospital of Shanghai Putuo District (Z.L.), Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Jie Liu
- Changning Maternity and Infant Health Hospital (D.S., J.Lu, Y.Z., J.Liu, B.Y., Y.G., X.W.), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences (D.S, J.Lu, Y.Z., J.Liu, X.W.), East China Normal University, Shanghai, People's Republic of China and Department of Cardiology, Central Hospital of Shanghai Putuo District (Z.L.), Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Zongjun Liu
- Changning Maternity and Infant Health Hospital (D.S., J.Lu, Y.Z., J.Liu, B.Y., Y.G., X.W.), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences (D.S, J.Lu, Y.Z., J.Liu, X.W.), East China Normal University, Shanghai, People's Republic of China and Department of Cardiology, Central Hospital of Shanghai Putuo District (Z.L.), Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Bingyi Yao
- Changning Maternity and Infant Health Hospital (D.S., J.Lu, Y.Z., J.Liu, B.Y., Y.G., X.W.), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences (D.S, J.Lu, Y.Z., J.Liu, X.W.), East China Normal University, Shanghai, People's Republic of China and Department of Cardiology, Central Hospital of Shanghai Putuo District (Z.L.), Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Yuanqing Guo
- Changning Maternity and Infant Health Hospital (D.S., J.Lu, Y.Z., J.Liu, B.Y., Y.G., X.W.), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences (D.S, J.Lu, Y.Z., J.Liu, X.W.), East China Normal University, Shanghai, People's Republic of China and Department of Cardiology, Central Hospital of Shanghai Putuo District (Z.L.), Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Xin Wang
- Changning Maternity and Infant Health Hospital (D.S., J.Lu, Y.Z., J.Liu, B.Y., Y.G., X.W.), Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences (D.S, J.Lu, Y.Z., J.Liu, X.W.), East China Normal University, Shanghai, People's Republic of China and Department of Cardiology, Central Hospital of Shanghai Putuo District (Z.L.), Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| |
Collapse
|
11
|
Maksymchuk O, Kashuba V. Dietary lipids and environmental xenobiotics as risk factors for prostate cancer: The role of cytochrome P450. Pharmacol Rep 2019; 71:826-832. [PMID: 31382168 DOI: 10.1016/j.pharep.2019.04.011] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2019] [Revised: 04/08/2019] [Accepted: 04/13/2019] [Indexed: 01/31/2023]
Abstract
Prostate cancer is one of the most common malignant neoplasms in men. Because of the increase in the number of cases as well as development of cancers resistant to conventional therapy, identification of the new molecular targets for the treatment and prevention is of great importance. For this purpose, many studies are aimed on revealing of molecular mechanisms of prostate cancer development. In this process, dietary lipids and environmental xenobiotics are largely involved and are considered as risk factors. A wide range of endogenous (cholesterol, polyunsaturated fatty acids, etc.) and exogenous (pollutants, drugs) compounds are metabolized in the human organism by cytochrome P450. From other hand, these compounds may alter cytochrome P450 expression levels, especially in prostate, which, in turn, affects cell metabolism. Cytochrome P450 is a member of signaling pathways, regulating cell cycle, apoptosis, invasion and adhesion. Hence, cytochrome P450 most probably plays the important role in initiation and progression of prostate cancer. Based on that, cytochrome P450 enzymes are considered as potential targets for the targeted therapy and prevention, and might serve as specific markers of malignant growth.
Collapse
Affiliation(s)
- Oksana Maksymchuk
- Department of Molecular Oncogenetics, Institute of Molecular Biology and Genetics NAS Ukraine, Kyiv, Ukraine.
| | - Vladimir Kashuba
- Department of Molecular Oncogenetics, Institute of Molecular Biology and Genetics NAS Ukraine, Kyiv, Ukraine; Department of Microbiology, Tumor and Cell Biology (MTC), Biomedicum, Karolinska Institute, Stockholm, Sweden.
| |
Collapse
|
12
|
Wang L, Chen W, Zha J, Yan Y, Wei Y, Chen X, Zhu X, Ge L. miR‑543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5. Oncol Rep 2019; 42:973-990. [PMID: 31322243 PMCID: PMC6667884 DOI: 10.3892/or.2019.7230] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2018] [Accepted: 07/03/2019] [Indexed: 02/07/2023] Open
Abstract
MicroRNAs (miRNAs/miRs) are small non-coding RNAs that can act as oncogenes or tumor-suppressor genes in human cancer. Previous studies have revealed that abnormal expression of miRNAs is closely associated with tumor cell cycle, differentiation, growth and apoptosis. miR-543 is expressed abnormally in a wide variety of cancers and has been associated with cellular proliferation, apoptosis, and invasion; however, the effect of miR-543 remains unknown in oral squamous cell carcinoma (OSCC). In the present study, the expression level of miR-543 in OSCC cell lines and tissues was investigated by RT-qPCR. A series of experiments was then performed to elucidate the functions of miR-543 in OSCC, such as CCK-8 assay, colony formation assay, flow cytometry, cell cycle distribution assay and cell apoptosis assay and Transwell assay. miR-543 expression was significantly upregulated in tumors from patients with OSCC and in OSCC cell lines. Overexpression of miR-543 promoted the proliferation, invasion and migration of OSCC cell lines, and inhibited cell apoptosis. In addition, the present study identified cytochrome P450 family 3 subfamily A member 5 (CYP3A5) as a direct target of miR-543 using software analysis and dual-luciferase reporter assays. In conclusion, the results of the present study suggest that miR-543 acts as a tumor promoter and serves a vital role in OSCC proliferation and invasion. These results confirm that miR-543 may serve as a potential novel target for the treatment of OSCC.
Collapse
Affiliation(s)
- Liping Wang
- Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
| | - Weihong Chen
- Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
| | - Jun Zha
- Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
| | - Yongyong Yan
- Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
| | - Yongxiang Wei
- Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
| | - Xili Chen
- Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
| | - Xinxin Zhu
- Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
| | - Linhu Ge
- Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
| |
Collapse
|
13
|
Lin JT, Chan TC, Li CF, Huan SKH, Tian YF, Liang PI, Pan CT, Shiue YL. Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder. APMIS 2019; 127:170-180. [PMID: 30803053 DOI: 10.1111/apm.12939] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2018] [Accepted: 02/11/2019] [Indexed: 12/15/2022]
Abstract
The objective of this study was to examine the expression level of cytochrome P450 4B1 (CYP4B1) protein and its clinical significance in specimens from patients with urothelial carcinomas (UC) including upper tract urothelial carcinoma (UTUC, n = 340) and urinary bladder urothelial carcinoma (UBUC, n = 295). Data mining on public domains identified five potential candidate transcripts which were downregulated in advanced UBUCs, indicating that it might implicate in UC progression. Immunohistochemistry was performed to analyze the CYP4B1 protein levels on 635 tissues from UC patients retrospectively. Immunoexpression of CYP4B1 was further estimated using the H-score method. Correlations between CYP4B1 H-score and important clinicopathological factors, as well as the significance of CYP4B1 expression level for disease-specific and metastasis-free survivals were evaluated. In UTUCs and UBUCs, 118 (34.7%) and 92 (31.2%) patients, respectively, were identified to be of CYP4B1 downregulation. The CYP4B1 expression level was found to be associated with several clinicopathological factors and patient survivals. Downregulation of CYP4B1 protein was correlated to advanced primary tumor (p < 0.001), nodal metastasis (p < 0.001), high histological grade (p = 0.001), vascular invasion (p < 0.001), perineural invasion (p = 0.017) and mitotic rate (p = 0.036) in UTUCs and/or UBUCs. Low CYP4B1 protein level independently predicted inferior disease-specific (p = 0.009; p < 0.001) and metastasis-free (p = 0.035; p < 0.001) survivals in UTUC and UBUC patients. Our findings showed that downregulation of CYP4B1 protein level is an independent unfavorable prognosticator. Loss of the CYP4B1 gene expression may play an important role in UC progression.
Collapse
Affiliation(s)
- Jen-Tai Lin
- Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
| | - Ti-Chun Chan
- Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.,Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan
| | - Chien-Feng Li
- Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan.,Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.,National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.,Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - Steven K H Huan
- Department of Medical Research, Chi-Mei Medical Center, Tainan, Taiwan
| | - Yu-Feng Tian
- Division of Colorectal Surgery, Department of Surgery, Chi-Mei Medical Center, Tainan, Taiwan.,Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan
| | - Peir-In Liang
- Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
| | - Cheng-Tang Pan
- Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.,Department of Mechanical and Electro-Mechanical Engineering, National Sun Yat-sen University, Kaohsiung, Taiwan
| | - Yow-Ling Shiue
- Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.,Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan
| |
Collapse
|
14
|
Glyakina AV, Strizhov NI, Karpov MV, Dovidchenko NV, Matkarimov BT, Isaeva LV, Efimova VS, Rubtsov MA, Novikova LA, Donova MV, Galzitskaya OV. Ile351, Leu355 and Ile461 residues are essential for catalytic activity of bovine cytochrome P450scc (CYP11A1). Steroids 2019; 143:80-90. [PMID: 30641046 DOI: 10.1016/j.steroids.2019.01.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/19/2018] [Revised: 12/28/2018] [Accepted: 01/07/2019] [Indexed: 11/23/2022]
Abstract
Cytochrome P450scc (CYP11A1) is a mammalian mitochondrial enzyme which catalyzes cholesterol side chain cleavage to form pregnenolone. Along with cholesterol, some other steroids including sterols with a branched side chain like β-sitosterol are the substrates for the enzyme, but the activity towards β-sitosterol is rather low. Modification of the catalytic site conformation could provide more effective β-sitosterol bioconversion by the enzyme. This study was aimed to find out the amino acid residues substitution of which could modify the conformation of the active site providing possible higher enzyme activity towards β-sitosterol. After structural and bioinformatics analysis three amino acid residues I351, L355, I461 were chosen. Molecular dynamics simulations of P450scc evidenced the stability of the wild type, double (I351A/L355A) and triple (I351A/L355A/I461A) mutants. Mutant variants of cDNA encoding P450scc with the single, double and triple mutations were obtained by site-directed mutagenesis. However, the experimental data indicate that the introduced single mutations Ile351A, Leu355A and Ile461A dramatically decrease the target catalytic activity of CYP11A1, and no activity was observed for double and triple mutants obtained. Therefore, isoleucine residues 351 and 461, and leucine residue 355 are important for the cytochrome P450scc functioning towards sterols both with unbranched (cholesterol) and branched (sitosterol) side chains.
Collapse
Affiliation(s)
- Anna V Glyakina
- Institute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region 142290, Russia; Institute of Mathematical Problems of Biology, Russian Academy of Sciences, Keldysh Institute of Applied Mathematics, Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russia
| | - Nicolai I Strizhov
- Institute of Biochemistry and Physiology of Microorganisms, Federal Research Center "Pushchino Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russia; Pharmins, Ltd., R&D, 142290 Pushchino, Moscow Region, Russia
| | - Mikhail V Karpov
- Institute of Biochemistry and Physiology of Microorganisms, Federal Research Center "Pushchino Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russia; Pharmins, Ltd., R&D, 142290 Pushchino, Moscow Region, Russia
| | - Nikita V Dovidchenko
- Institute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region 142290, Russia
| | | | - Ludmila V Isaeva
- Belozersky Institute of Physico-Chemical Biology, M.V. Lomonosov Moscow State University, Leninskie Gory, 1/40, 119234 Moscow, Russia
| | - Vera S Efimova
- Department of Molecular Biology, Faculty of Biology, M.V. Lomonosov Moscow State University, Leninskie Gory, 1/12, 119234 Moscow, Russia
| | - Mikhail A Rubtsov
- Department of Molecular Biology, Faculty of Biology, M.V. Lomonosov Moscow State University, Leninskie Gory, 1/12, 119234 Moscow, Russia; Department of Biochemistry, Institute of Translational Medicine and Biotechnology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
| | - Ludmila A Novikova
- Belozersky Institute of Physico-Chemical Biology, M.V. Lomonosov Moscow State University, Leninskie Gory, 1/40, 119234 Moscow, Russia
| | - Marina V Donova
- Institute of Biochemistry and Physiology of Microorganisms, Federal Research Center "Pushchino Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russia; Pharmins, Ltd., R&D, 142290 Pushchino, Moscow Region, Russia.
| | - Oxana V Galzitskaya
- Institute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region 142290, Russia.
| |
Collapse
|
15
|
Poynton HC, Hasenbein S, Benoit JB, Sepulveda MS, Poelchau MF, Hughes DST, Murali SC, Chen S, Glastad KM, Goodisman MAD, Werren JH, Vineis JH, Bowen JL, Friedrich M, Jones J, Robertson HM, Feyereisen R, Mechler-Hickson A, Mathers N, Lee CE, Colbourne JK, Biales A, Johnston JS, Wellborn GA, Rosendale AJ, Cridge AG, Munoz-Torres MC, Bain PA, Manny AR, Major KM, Lambert FN, Vulpe CD, Tuck P, Blalock BJ, Lin YY, Smith ME, Ochoa-Acuña H, Chen MJM, Childers CP, Qu J, Dugan S, Lee SL, Chao H, Dinh H, Han Y, Doddapaneni H, Worley KC, Muzny DM, Gibbs RA, Richards S. The Toxicogenome of Hyalella azteca: A Model for Sediment Ecotoxicology and Evolutionary Toxicology. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2018; 52:6009-6022. [PMID: 29634279 DOI: 10.15482/usda.adc/1415994] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Hyalella azteca is a cryptic species complex of epibenthic amphipods of interest to ecotoxicology and evolutionary biology. It is the primary crustacean used in North America for sediment toxicity testing and an emerging model for molecular ecotoxicology. To provide molecular resources for sediment quality assessments and evolutionary studies, we sequenced, assembled, and annotated the genome of the H. azteca U.S. Lab Strain. The genome quality and completeness is comparable with other ecotoxicological model species. Through targeted investigation and use of gene expression data sets of H. azteca exposed to pesticides, metals, and other emerging contaminants, we annotated and characterized the major gene families involved in sequestration, detoxification, oxidative stress, and toxicant response. Our results revealed gene loss related to light sensing, but a large expansion in chemoreceptors, likely underlying sensory shifts necessary in their low light habitats. Gene family expansions were also noted for cytochrome P450 genes, cuticle proteins, ion transporters, and include recent gene duplications in the metal sequestration protein, metallothionein. Mapping of differentially expressed transcripts to the genome significantly increased the ability to functionally annotate toxicant responsive genes. The H. azteca genome will greatly facilitate development of genomic tools for environmental assessments and promote an understanding of how evolution shapes toxicological pathways with implications for environmental and human health.
Collapse
Affiliation(s)
- Helen C Poynton
- School for the Environment , University of Massachusetts Boston , Boston , Massachusetts 02125 United States
| | - Simone Hasenbein
- Aquatic Systems Biology Unit , Technical University of Munich , D-85354 Freising , Germany
| | - Joshua B Benoit
- Department of Biological Sciences , University of Cincinnati , Cincinnati , Ohio 45221 United States
| | - Maria S Sepulveda
- Forestry and Natural Resources , Purdue University , West Lafayette , Indiana 47907 United States
| | - Monica F Poelchau
- Agricultural Research Service, National Agricultural Library , U.S. Department of Agriculture , Beltsville , Maryland 20705 United States
| | - Daniel S T Hughes
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Shwetha C Murali
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Shuai Chen
- Forestry and Natural Resources , Purdue University , West Lafayette , Indiana 47907 United States
- OmicSoft Corporation, Cary , North Carolina 27513 United States
| | - Karl M Glastad
- Perelman School of Medicine , University of Pennsylvania , Philadelphia , Pennsylvania 19104 United States
| | - Michael A D Goodisman
- School of Biological Sciences , Georgia Institute of Technology , Atlanta , Georgia 30332 United States
| | - John H Werren
- Biology Department , University of Rochester , Rochester , New York 14627 United States
| | - Joseph H Vineis
- Department of Marine and Environmental Sciences, Marine Science Center , Northeastern University , Nahant , Massachusetts 01908 United States
| | - Jennifer L Bowen
- Department of Marine and Environmental Sciences, Marine Science Center , Northeastern University , Nahant , Massachusetts 01908 United States
| | - Markus Friedrich
- Department of Biological Sciences , Wayne State University , Detroit Michigan 48202 United States
| | - Jeffery Jones
- Department of Biological Sciences , Wayne State University , Detroit Michigan 48202 United States
| | - Hugh M Robertson
- Department of Entomology , University of Illinois at Urbana-Champaign , Urbana , Illinois 61801 United States
| | - René Feyereisen
- Department of Plant and Environmental Sciences , University of Copenhagen , DK-1871 Frederiksberg , Denmark
| | - Alexandra Mechler-Hickson
- Center of Rapid Evolution (CORE) and Department of Integrative Biology , University of Wisconsin , Madison , Wisconsin 53706 United States
| | - Nicholas Mathers
- Center of Rapid Evolution (CORE) and Department of Integrative Biology , University of Wisconsin , Madison , Wisconsin 53706 United States
| | - Carol Eunmi Lee
- Center of Rapid Evolution (CORE) and Department of Integrative Biology , University of Wisconsin , Madison , Wisconsin 53706 United States
| | - John K Colbourne
- School of Biosciences , University of Birmingham , Birmingham B15 2TT U.K
| | - Adam Biales
- National Exposure Research Laboratory , United States Environmental Protection Agency , Cincinnati , Ohio 45268 United States
| | - J Spencer Johnston
- Department of Entomology , Texas A&M University , College Station , Texas 77843 United States
| | - Gary A Wellborn
- Department of Biology , University of Oklahoma , Norman , Oklahoma 73019 United States
| | - Andrew J Rosendale
- Department of Biological Sciences , University of Cincinnati , Cincinnati , Ohio 45221 United States
| | - Andrew G Cridge
- Laboratory for Evolution and Development, Department of Biochemistry , University of Otago , Dunedin , 9054 New Zealand
| | - Monica C Munoz-Torres
- Environmental Genomics and Systems Biology Division , Lawrence Berkeley National Laboratory , Berkeley , California 94720 United States
| | - Peter A Bain
- Commonwealth Scientific and Industrial Research Organisation (CSIRO), Urrbrae SA 5064 Australia
| | - Austin R Manny
- Department of Microbiology & Cell Science , University of Florida , Gainesville , Florida 32611 United States
| | - Kaley M Major
- School for the Environment , University of Massachusetts Boston , Boston , Massachusetts 02125 United States
| | - Faith N Lambert
- Center for Environmental and Human Toxicology, Department of Physiological Sciences , University of Florida , Gainesville , Florida 32611 United States
| | - Chris D Vulpe
- Center for Environmental and Human Toxicology, Department of Physiological Sciences , University of Florida , Gainesville , Florida 32611 United States
| | - Padrig Tuck
- School for the Environment , University of Massachusetts Boston , Boston , Massachusetts 02125 United States
| | - Bonnie J Blalock
- School for the Environment , University of Massachusetts Boston , Boston , Massachusetts 02125 United States
| | - Yu-Yu Lin
- Graduate Institute of Biomedical Electronics and Bioinformatics , National Taiwan University , Taipei , 10617 Taiwan
| | - Mark E Smith
- McConnell Group, Cincinnati , Ohio 45268 , United States
| | - Hugo Ochoa-Acuña
- Forestry and Natural Resources , Purdue University , West Lafayette , Indiana 47907 United States
| | - Mei-Ju May Chen
- Graduate Institute of Biomedical Electronics and Bioinformatics , National Taiwan University , Taipei , 10617 Taiwan
| | - Christopher P Childers
- Agricultural Research Service, National Agricultural Library , U.S. Department of Agriculture , Beltsville , Maryland 20705 United States
| | - Jiaxin Qu
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Shannon Dugan
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Sandra L Lee
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Hsu Chao
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Huyen Dinh
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Yi Han
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | | | - Kim C Worley
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
- Department of Molecular and Human Genetics , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Donna M Muzny
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Richard A Gibbs
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Stephen Richards
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| |
Collapse
|
16
|
Poynton HC, Hasenbein S, Benoit JB, Sepulveda MS, Poelchau MF, Hughes DST, Murali SC, Chen S, Glastad KM, Goodisman MAD, Werren JH, Vineis JH, Bowen JL, Friedrich M, Jones J, Robertson HM, Feyereisen R, Mechler-Hickson A, Mathers N, Lee CE, Colbourne JK, Biales A, Johnston JS, Wellborn GA, Rosendale AJ, Cridge AG, Munoz-Torres MC, Bain PA, Manny AR, Major KM, Lambert FN, Vulpe CD, Tuck P, Blalock BJ, Lin YY, Smith ME, Ochoa-Acuña H, Chen MJM, Childers CP, Qu J, Dugan S, Lee SL, Chao H, Dinh H, Han Y, Doddapaneni H, Worley KC, Muzny DM, Gibbs RA, Richards S. The Toxicogenome of Hyalella azteca: A Model for Sediment Ecotoxicology and Evolutionary Toxicology. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2018; 52:6009-6022. [PMID: 29634279 PMCID: PMC6091588 DOI: 10.1021/acs.est.8b00837] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
Hyalella azteca is a cryptic species complex of epibenthic amphipods of interest to ecotoxicology and evolutionary biology. It is the primary crustacean used in North America for sediment toxicity testing and an emerging model for molecular ecotoxicology. To provide molecular resources for sediment quality assessments and evolutionary studies, we sequenced, assembled, and annotated the genome of the H. azteca U.S. Lab Strain. The genome quality and completeness is comparable with other ecotoxicological model species. Through targeted investigation and use of gene expression data sets of H. azteca exposed to pesticides, metals, and other emerging contaminants, we annotated and characterized the major gene families involved in sequestration, detoxification, oxidative stress, and toxicant response. Our results revealed gene loss related to light sensing, but a large expansion in chemoreceptors, likely underlying sensory shifts necessary in their low light habitats. Gene family expansions were also noted for cytochrome P450 genes, cuticle proteins, ion transporters, and include recent gene duplications in the metal sequestration protein, metallothionein. Mapping of differentially expressed transcripts to the genome significantly increased the ability to functionally annotate toxicant responsive genes. The H. azteca genome will greatly facilitate development of genomic tools for environmental assessments and promote an understanding of how evolution shapes toxicological pathways with implications for environmental and human health.
Collapse
Affiliation(s)
- Helen C Poynton
- School for the Environment , University of Massachusetts Boston , Boston , Massachusetts 02125 United States
| | - Simone Hasenbein
- Aquatic Systems Biology Unit , Technical University of Munich , D-85354 Freising , Germany
| | - Joshua B Benoit
- Department of Biological Sciences , University of Cincinnati , Cincinnati , Ohio 45221 United States
| | - Maria S Sepulveda
- Forestry and Natural Resources , Purdue University , West Lafayette , Indiana 47907 United States
| | - Monica F Poelchau
- Agricultural Research Service, National Agricultural Library , U.S. Department of Agriculture , Beltsville , Maryland 20705 United States
| | - Daniel S T Hughes
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Shwetha C Murali
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Shuai Chen
- Forestry and Natural Resources , Purdue University , West Lafayette , Indiana 47907 United States
- OmicSoft Corporation, Cary , North Carolina 27513 United States
| | - Karl M Glastad
- Perelman School of Medicine , University of Pennsylvania , Philadelphia , Pennsylvania 19104 United States
| | - Michael A D Goodisman
- School of Biological Sciences , Georgia Institute of Technology , Atlanta , Georgia 30332 United States
| | - John H Werren
- Biology Department , University of Rochester , Rochester , New York 14627 United States
| | - Joseph H Vineis
- Department of Marine and Environmental Sciences, Marine Science Center , Northeastern University , Nahant , Massachusetts 01908 United States
| | - Jennifer L Bowen
- Department of Marine and Environmental Sciences, Marine Science Center , Northeastern University , Nahant , Massachusetts 01908 United States
| | - Markus Friedrich
- Department of Biological Sciences , Wayne State University , Detroit Michigan 48202 United States
| | - Jeffery Jones
- Department of Biological Sciences , Wayne State University , Detroit Michigan 48202 United States
| | - Hugh M Robertson
- Department of Entomology , University of Illinois at Urbana-Champaign , Urbana , Illinois 61801 United States
| | - René Feyereisen
- Department of Plant and Environmental Sciences , University of Copenhagen , DK-1871 Frederiksberg , Denmark
| | - Alexandra Mechler-Hickson
- Center of Rapid Evolution (CORE) and Department of Integrative Biology , University of Wisconsin , Madison , Wisconsin 53706 United States
| | - Nicholas Mathers
- Center of Rapid Evolution (CORE) and Department of Integrative Biology , University of Wisconsin , Madison , Wisconsin 53706 United States
| | - Carol Eunmi Lee
- Center of Rapid Evolution (CORE) and Department of Integrative Biology , University of Wisconsin , Madison , Wisconsin 53706 United States
| | - John K Colbourne
- School of Biosciences , University of Birmingham , Birmingham B15 2TT U.K
| | - Adam Biales
- National Exposure Research Laboratory , United States Environmental Protection Agency , Cincinnati , Ohio 45268 United States
| | - J Spencer Johnston
- Department of Entomology , Texas A&M University , College Station , Texas 77843 United States
| | - Gary A Wellborn
- Department of Biology , University of Oklahoma , Norman , Oklahoma 73019 United States
| | - Andrew J Rosendale
- Department of Biological Sciences , University of Cincinnati , Cincinnati , Ohio 45221 United States
| | - Andrew G Cridge
- Laboratory for Evolution and Development, Department of Biochemistry , University of Otago , Dunedin , 9054 New Zealand
| | - Monica C Munoz-Torres
- Environmental Genomics and Systems Biology Division , Lawrence Berkeley National Laboratory , Berkeley , California 94720 United States
| | - Peter A Bain
- Commonwealth Scientific and Industrial Research Organisation (CSIRO), Urrbrae SA 5064 Australia
| | - Austin R Manny
- Department of Microbiology & Cell Science , University of Florida , Gainesville , Florida 32611 United States
| | - Kaley M Major
- School for the Environment , University of Massachusetts Boston , Boston , Massachusetts 02125 United States
| | - Faith N Lambert
- Center for Environmental and Human Toxicology, Department of Physiological Sciences , University of Florida , Gainesville , Florida 32611 United States
| | - Chris D Vulpe
- Center for Environmental and Human Toxicology, Department of Physiological Sciences , University of Florida , Gainesville , Florida 32611 United States
| | - Padrig Tuck
- School for the Environment , University of Massachusetts Boston , Boston , Massachusetts 02125 United States
| | - Bonnie J Blalock
- School for the Environment , University of Massachusetts Boston , Boston , Massachusetts 02125 United States
| | - Yu-Yu Lin
- Graduate Institute of Biomedical Electronics and Bioinformatics , National Taiwan University , Taipei , 10617 Taiwan
| | - Mark E Smith
- McConnell Group, Cincinnati , Ohio 45268 , United States
| | - Hugo Ochoa-Acuña
- Forestry and Natural Resources , Purdue University , West Lafayette , Indiana 47907 United States
| | - Mei-Ju May Chen
- Graduate Institute of Biomedical Electronics and Bioinformatics , National Taiwan University , Taipei , 10617 Taiwan
| | - Christopher P Childers
- Agricultural Research Service, National Agricultural Library , U.S. Department of Agriculture , Beltsville , Maryland 20705 United States
| | - Jiaxin Qu
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Shannon Dugan
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Sandra L Lee
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Hsu Chao
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Huyen Dinh
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Yi Han
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | | | - Kim C Worley
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
- Department of Molecular and Human Genetics , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Donna M Muzny
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Richard A Gibbs
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| | - Stephen Richards
- Human Genome Sequencing Center , Baylor College of Medicine , Houston , Texas 77030 United States
| |
Collapse
|
17
|
Elshater AEA, Haridy MA, Salman MM, Fayyad AS, Hammad S. Fullerene C60 nanoparticles ameliorated cyclophosphamide-induced acute hepatotoxicity in rats. Biomed Pharmacother 2018; 97:53-59. [DOI: 10.1016/j.biopha.2017.10.134] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2017] [Revised: 09/30/2017] [Accepted: 10/23/2017] [Indexed: 10/18/2022] Open
|
18
|
Abstract
BACKGROUND The identification of prognostic biomarkers for cancer patients is essential for cancer research. These days, DNA methylation has been proved to be associated with cancer prognosis. However, there are few methods which identify the prognostic markers based on DNA methylation data systematically, especially considering the interaction among DNA methylation sites. METHODS In this paper, we first evaluated the stabilities of microRNA, mRNA, and DNA methylation data in prognosis of cancer. After that, a rank-based method was applied to construct a DNA methylation interaction network. In this network, nodes with the largest degrees (10% of all the nodes) were selected as hubs. Cox regression was applied to select the hubs as prognostic signature. In this prognostic signature, DNA methylation levels of each DNA methylation site are correlated with the outcomes of cancer patients. After obtaining these prognostic genes, we performed the survival analysis in the training group and the test group to verify the reliability of these genes. RESULTS We applied our method in three cancers (ovarian cancer, breast cancer and Glioblastoma Multiforme). In all the three cancers, there are more common ones of prognostic genes selected from different samples in DNA methylation data, compared with gene expression data and miRNA expression data, which indicates the DNA methylation data may be more stable in cancer prognosis. Power-law distribution fitting suggests that the DNA methylation interaction networks are scale-free. And the hubs selected from the three networks are all enriched by cancer related pathways. The gene signatures were obtained for the three cancers respectively, and survival analysis shows they can distinguish the outcomes of tumor patients in both the training data sets and test data sets, which outperformed the control signatures. CONCLUSIONS A computational method was proposed to construct DNA methylation interaction network and this network could be used to select prognostic signatures in cancer.
Collapse
Affiliation(s)
- Wei-Lin Hu
- College of Science, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China
| | - Xiong-Hui Zhou
- College of Informatics, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
| |
Collapse
|
19
|
Jeelani R, Khan SN, Shaeib F, Kohan-Ghadr HR, Aldhaheri SR, Najafi T, Thakur M, Morris R, Abu-Soud HM. Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality. Free Radic Biol Med 2017; 110:11-18. [PMID: 28499912 PMCID: PMC6854673 DOI: 10.1016/j.freeradbiomed.2017.05.006] [Citation(s) in RCA: 102] [Impact Index Per Article: 14.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2016] [Revised: 05/03/2017] [Accepted: 05/07/2017] [Indexed: 12/30/2022]
Abstract
Cyclophosphamide (CTX) is a chemotherapeutic agent widely used to treat ovarian, breast, and hematological cancers as well as autoimmune disorders. Such chemotherapy is associated with reproductive failure and premature ovarian insufficiency. The mechanism by which CTX and/or its main metabolite, acrolein, affect female fertility remains unclear, but it is thought to be caused by an overproduction of reactive oxygen species (ROS). Here, we investigated the effect of CTX on metaphase II mouse oocytes obtained from treated animals (120mg/kg, 24h of single treatment), and oocytes directly exposed to increasing concentrations of CTX and acrolein (n=480; 0, 5, 10, 25, 50, and 100μM) with and without cumulus cells (CCs) for 45min which correlates to the time of maximum peak plasma concentrations after administration. Oocytes were fixed and subjected to indirect immunofluorescence and were scored based on microtubule spindle structure (MT) and chromosomal alignment (CH). Generation of ROS was evaluated using the Cellular Reactive Oxygen Species Detection Assay Kit. Deterioration of oocyte quality was noted when oocytes were obtained from CTX treated mice along with CTX and acrolein treated oocytes in a dose-dependent manner as shown by an increase in poor scores. Acrolein had an impact at a significantly lower level as compared to CTX, plateau at 10μM versus 50μM, respectively. These variation is are associated with the higher amount of ROS generated with acrolein exposure as compared to CTX (p<0.05). Utilization of antioxidant therapy and acrolein scavengers may mitigate the damaging effects of these compounds and help women undergoing such treatment.
Collapse
Affiliation(s)
- Roohi Jeelani
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA
| | - Sana N Khan
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA
| | - Faten Shaeib
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA
| | - Hamid-Reza Kohan-Ghadr
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA
| | - Sarah R Aldhaheri
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA
| | - Tohid Najafi
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA
| | - Mili Thakur
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA; Division of Genetic, Genomic and Metabolic Disorders, Department of Pediatrics and Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI 48201, USA
| | - Robert Morris
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA; Karmanos Cancer Institute, Detroit, MI 48201, USA
| | - Husam M Abu-Soud
- Department of Obstetrics and Gynecology, The C.S. Mott Center for Human Growth and Development, Wayne State University School of Medicine, Detroit, MI 48201, USA; Department of Biochemistry and Molecular Biology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
| |
Collapse
|
20
|
Protective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in Mice. PLoS One 2016; 11:e0165667. [PMID: 27802299 PMCID: PMC5089748 DOI: 10.1371/journal.pone.0165667] [Citation(s) in RCA: 43] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2016] [Accepted: 10/14/2016] [Indexed: 12/13/2022] Open
Abstract
Clinical application of cyclophosphamide (CP) as an anticancer drug is often limited due to its toxicity. CP is metabolized mainly in the liver by cytochrome P450 system into acrolein which is the proximate toxic metabolite. Many different natural antioxidants were found to alleviate the toxic effects of various toxic agents via different mechanisms. Therefore, the present study aimed at investigating the role of essential oils extracted from fennel, cumin and clove as natural antioxidants in the alleviation of hepatotoxicity induced by CP through assessment of hepatotoxicity biomarkers (AST, ALT, ALP), histopathology of liver tissues as well as other biochemical parameters involved in the metabolism of CP. The data of the present study showed that treatment of male mice with cyclophosphamide (2.5 mg/Kg BW) as repeated dose for 28 consecutive days was found to induce hepatotoxicity through the elevation in the activities of AST, ALT, and ALP. Combined administration of any of these oils with CP to mice partially normalized the altered hepatic biochemical markers caused by CP, whereas administration of fennel, clove or cumin essential oils alone couldn't change liver function indices. Moreover, CP caused histological changes in livers of mice including swelling and dilation in sinusoidal space, inflammation in portal tract and hepatocytes, as well as, hyperplasia in Kuppfer cells. However, co-administration of any of the essential oils with CP alleviated to some extent the changes caused by CP but not as the normal liver. CP was also found to induce free radical levels (measured as thiobarbituric acid reactive substances) and inhibited the activities of superoxide dismutase, glutathione reductase, and catalase as well as activities and protein expressions of both glutathione S-transferase (GSTπ) and glutathione peroxidase. Essential oils restored changes in activities of antioxidant enzymes (SOD, CAT, GR, GST, and GPx) caused by CP to their normal levels compared to control group. In addition, treatment of mice with CP was found to induce the protein expression of CYP 3A4, 2B1/2, 2C6, 2C23. Moreover, the present study showed that essential oils reduced the expression of CYPs 2E1, 3A4 but could not restore the expression of CYP 2C6 and 2C23 compared to CP-treated mice. Interestingly, pretreatment of mice with essential oil of clove was found to restore activities of DMN-dI, AHH, and ECOD which were induced by CP to their normal control levels. It is concluded that EOs showed a marked hepatoprotective effect against hepatotoxicity induced by CP. In addition, co-administration of CP with any of these oils might be used as a new strategy for cancer treatment to alleviate the hepatotoxicity induced by CP.
Collapse
|
21
|
Yang C, Cheng Y, Zhao J, Rong J. Releasing Nrf2 to promote neurite outgrowth. Neural Regen Res 2015; 10:1934-5. [PMID: 26889175 PMCID: PMC4730811 DOI: 10.4103/1673-5374.169618] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/30/2015] [Indexed: 12/17/2022] Open
Affiliation(s)
- Chuanbin Yang
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China
| | - Yuanyuan Cheng
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China
| | - Jiao Zhao
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China
| | - Jianhui Rong
- School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China
| |
Collapse
|